Literature DB >> 9112914

Somatostatin receptor scintigraphy in medullary thyroid carcinoma.

L E Tisell1, H Ahlman, B Wängberg, G Hansson, J Mölne, O Nilsson, G Lindstedt, M Fjälling, E Forssell-Aronsson.   

Abstract

BACKGROUND: 111In-radiolabelled (DTPA-D-Phe1)-octreotide scintigraphy can be used to localize neuroendocrine tumours expressing somatostatin receptors (SSTRs). The aim of this paper was to analyse the importance of tumour volume and growth for the visualization by SSTR scintigraphy of metastases from medullary thyroid carcinoma (MTC).
METHODS: Serum calcitonin concentrations were used to estimate volume and growth rate of MTC. Twenty-two patients who had persistent hypercalcitoninaemia after total thyroidectomy for MTC, indicating the presence of metastases, were studied.
RESULTS: SSTR scintigraphy visualized 15 tumours in 11 patients. Patients with scintigraphically visualized tumours had higher serum calcitonin and carcinoembryonic antigen concentrations and larger tumours, and the serum calcitonin concentration increased more rapidly with time. Tumour-associated symptoms and death from MTC occurred only in patients with scintigraphically visualized tumours.
CONCLUSION: Scintigraphically visualized tumours grow more rapidly and are more aggressive than nonvisualized lesions. SSTR scintigraphy can be helpful in the planning of palliative surgery for MTC and for diagnosing distant metastases, but cannot localize microscopic metastases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9112914

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  (111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents.

Authors:  Maya Lodish; Urania Dagalakis; Clara C Chen; Ninet Sinaii; Patricia Whitcomb; Alberta Aikin; Eva Dombi; Leigh Marcus; Brigitte Widemann; Elizabeth Fox; Meredith Chuk; Frank Balis; Samuel Wells; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2011-12-07       Impact factor: 5.958

Review 2.  Octreoscan radioreceptor imaging.

Authors:  Aart J van der Lely; Wouter W de Herder; Eric P Krenning; Dik J Kwekkeboom
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

Review 3.  Somatostatin receptor SPECT.

Authors:  Giovanna Pepe; Roy Moncayo; Emilio Bombardieri; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

Review 4.  Somatostatin receptors and their interest in diagnostic pathology.

Authors:  Marco Volante; Francesca Bozzalla-Cassione; Mauro Papotti
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

5.  Routine preoperative (111)In-octreotide scintigraphy in patients with medullary thyroid cancer.

Authors:  Jakob Dahlberg; Per Bümming; Peter Gjertsson; Svante Jansson
Journal:  Langenbecks Arch Surg       Date:  2013-05-19       Impact factor: 3.445

6.  Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.

Authors:  O Nilsson; L Kölby; B Wängberg; A Wigander; H Billig; L William-Olsson; M Fjälling; E Forssell-Aronsson; H Ahlman
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

7.  Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid.

Authors:  L E Tisell; H Ahlman; B Wängberg; L Kölby; M Fjälling; E Forssell-Aronsson; J Mölne; O Nilsson
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  Chronic bronchitis mimicking metastases from thyroid medullary carcinoma demonstrated by indium-111 pentetreotide scintigraphy.

Authors:  Savas Karyagar; Mehmet Mulazimoglu; Sevda S Karyagar; Metin Halac; Tevfik Ozpacaci
Journal:  Cancer Imaging       Date:  2008-04-24       Impact factor: 3.909

9.  The Ki67 index a prognostic marker in medullary thyroid carcinoma.

Authors:  L E Tisell; A Oden; A Muth; G Altiparmak; J Mõlne; H Ahlman; O Nilsson
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

10.  The relevance of somatostatin receptors in thyroid neoplasia.

Authors:  H Ahlman; L E Tisell; B Wängberg; M Fjälling; E Forssell-Aronsson; L Kölby; O Nilsson
Journal:  Yale J Biol Med       Date:  1997 Sep-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.